Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (PACTR202607921693996) titled 'Post-Discharge malaria chemoprevention (PDMC) plus R21/Matrix-M™ vaccination' on July 27.
Study Type: Interventional
Study Design:
Parallel: different groups receive different interventions at same time during study,Randomised,Simple randomization using a randomization table created by a computer software program,Sealed opaque envelopes
Primary Sponsor: Kumasi Center for Collaborative Research in Tropical Medicine
Condition:
Haematological Disorders
Malaria
Paediatrics
Haematological Disorders
Malaria
Paediatrics
Intervention:
R21Matrix vaccine and Dihydroartemisinin piperaquine DHAPPQ
Dihydroar...